CUSIP: 576810105
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
45,435,751
-
Share change
-
-2,010,926
-
Total reported value
-
$34,809,019
-
Price per share
-
$0.77
-
Number of holders
-
59
-
Value change
-
-$1,558,372
-
Number of buys
-
20
-
Number of sells
-
19
Quarterly Holders Quick Answers
What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2020
-
Previous quarter:
Q2 2020
Recent filing periods for CUSIP 576810105:
Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q3 2020
As of 30 Sep 2020,
MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,435,751 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, Vivo Capital, LLC, VANGUARD GROUP INC, BlackRock Inc., TWO SIGMA INVESTMENTS, LP, VICTORY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, BRIDGEWAY CAPITAL MANAGEMENT INC, and ROYAL BANK OF CANADA.
This page lists
59
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.